EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 2 July 2020

EU Pharmaceutical Strategy could be a lost opportunity if action is not taken now

Parliament Magazine

When the Roadmap to the EU’s Pharmaceutical strategy was announced by Health Commissioner Stella Kyriakides, she underlined that “The EU needs a pharmaceutical strategy that makes essential medicines available to all and cements our global leadership on innovation in pharmaceuticals”. Now more than ever before, the COVID-19 crisis has shown that the world looks to medical innovation to fight global health threats and to tackle our existing health challenges. In its current form, the pharma strategy roadmap lacks the necessary drivers of innovation to put Europe back at the forefront of medical discovery. Read more

News

Time to act together: patients wait more than 6 times longer for access to new medicines in...
02 July 2020

The EFPIA Patients WAIT Survey and the EFPIA/CRA analysis should serve as a starting point for an informed discussion... Read more

EFPIA announces new members at a critical time for European healthcare and the research-based...
30 June 2020

EFPIA welcomes Stallergenes Greer Ltd and Gilead Sciences as new members of EFPIA, as well as 14 new SME members and... Read more

Blogs

Make the regulatory system fit for the future of medical innovation
30 June 2020 - Nathalie Moll

The “new normal” in regulatory terms should aim at decreasing complexity while ensuring the quality, safety and efficacy... Read more

ICH - Instilling ‘harmony’ for 30 years, and never more relevant than today!
29 June 2020 - Pär Tellner

Harmonisation of requirements for drug development and manufacturing will contribute to the objective of safe, effective... Read more

Videos

Keep the Spark Alive: the Regulatory Road to Innovation
Europe’s regulatory system is designed to ensure that new treatments for patients are safe and effective. It has... Read more

Treatment Outcomes 2020/30
This international conference, organized under the patronage of the Presidency of the Council of the European Union,... Read more

Our latest publications

2020: The Pharmaceutical Industry in Figures
30 June 2020 (Publications)

Our annual statistics leaflet Read more

EFPIA Patients W.A.I.T. Indicator 2019 Survey
01 July 2020 (Publications)

The yearly EFPIA Patients WAIT survey is now published Read more

The root causes of unavailability and delay to innovative medicines
01 July 2020 (Publications)

Analysis developed with the support of Charles Rivers Associates (CRA) Read more

What we are reading

IMI-supported Ebola vaccine regimen gets green light
On 01 July 2020 (IMI website)

The European Commission has officially granted market authorisation for an IMI-supported Ebola vaccine regimen, which... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu